Early response as predictor of final remission in elderly depressed patients
Authors:
- 22 October 2009
- journal article
- research article
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 24 (11) , 1299-1303
Abstract
Background Several studies have attempted to predict the final response or remission based on improvement during the early course of treatment of major depression. There is however a great variation in cut offs used to define early response and in the optimal week to predict final results. Objective To compare different cut offs at different time points early in the treatment of elderly depressed patients. Method A 12 week randomised, controlled trial in 81 elderly inpatients with DSM–IV major depression comparing venlafaxine with nortriptyline. At least 20, 25, 30 or 50% improvement was analysed after 1, 3 and 5 weeks using the Hamilton Depression Rating Scale and the Montgomery Asberg Depression Rating Scale. We plotted sensitivity against 1—specificity and calculated areas under the curve (AUCs). Results The highest percentage of correctly classified patients is found using at least 50% decrease as cut off in week 5, with acceptable sensitivity (81.8%) and specificity (87.4%). In week 5, the AUCs were 0.891 (95% CI 0.798–0.984) and 0.866 (95% CI 0.789–0.983) for the HAM‐D and MADRS, respectively. Conclusions Combining the results from our study and the other studies addressing this issue, we suggest that the treatment should be changed in the elderly if after 3–4 weeks less than 30% improvement in depression score has been achieved. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
This publication has 9 references indexed in Scilit:
- Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double‐blind, controlled trialInternational Journal of Geriatric Psychiatry, 2007
- What is the Optimal Duration of a Short-term Antidepressant Trial When Treating Geriatric Depression?Journal of Clinical Psychopharmacology, 2006
- Predicting Stable Treatment Response in Patients with Major Depression Treated with Hypericum Extract WS® 5570/5572Pharmacopsychiatry, 2005
- Optimal Length of Antidepressant Trials in Late-Life DepressionJournal of Clinical Psychopharmacology, 2005
- Early Improvement Under Mirtazapine and Paroxetine Predicts Later Stable Response and Remission With High Sensitivity in Patients With Major DepressionThe Journal of Clinical Psychiatry, 2003
- When Should a Trial of Fluoxetine for Major Depression Be Declared Failed?American Journal of Psychiatry, 2003
- How Fast Are Antidepressants?The Journal of Clinical Psychiatry, 2000
- Timing of Onset of Antidepressant Response With Fluoxetine TreatmentAmerican Journal of Psychiatry, 2000
- Predicting Response to Fluoxetine in Geriatric Patients With Major DepressionJournal of Clinical Psychopharmacology, 1995